Advice Pool - Health and Fitness

What is Psoriasis: Psoriasis is a disease whose main symptom is gray colored patches on the skin which are red and inflamed underneath. In the United States, it affects 2 to 2.8 percent of the

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

population, or between 5.8 and 7.8 million people. Commonly affected areas include the scalp, knees, elbows, groin, palms. Psoriasis is autoimmune in origin, and therefore it is not contagious.

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

Around a fourth of the people with psoriasis also suffer from a form pf arthritis, called psoriatic arthritis, which is similar to rheumatoid arthritis in its symptoms.

What Causes Psoriasis:

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Psoriasis is powered by the immune system, involving a type of white blood cell called a T Cell. Normally, T cells help protect the body against infection and disease. In the case of psoriasis

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

, T cells are put into action by mistake and become so active that they trigger other immune responses, which lead to inflammation and to rapid turnover of skin cells. These cells pile up on th

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e surface of the skin, forming itchy patches or plaques. The first outbreak of psoriasis is often triggered by emotional or mental stress or physical skin injury, but heredity is a major factor

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

as well. In about one-third of the cases, there is a family history of psoriasis. Researchers have studied a large number of families affected by psoriasis and identified genes linked to the d

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

sease. People with psoriasis may notice that there are times when their skin worsens, then improves. Conditions that may cause flareups include infections, stress, and changes in climate that d

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ry the skin. Also, certain medicines, including lithium and beta blockers, which are prescribed for high blood pressure, may trigger an outbreak or worsen the disease.

Psoriasis Treatment: Doc

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

tors generally treat psoriasis in steps based on the severity of the disease, size of the areas involved, type of psoriasis, and the patient's response to initial treatments. This is sometimes

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

called the "1-2-3" approach. In step 1, medicines are applied to the skin (topical treatment). Step 2 uses ultraviolet light treatments (phototherapy). Step 3 involves taking medicines by mouth

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

or injection that treat the whole immune system (called systemic therapy). Over time, affected skin can become resistant to treatment, especially when topical corticosteroids are used. Also, a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

treatment that works very well in one person may have little effect in another. Thus, doctors often use a trial-and-error approach to find a treatment that works, and they may switch treatment

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

s periodically (for example, every 12 to 24 months) if a treatment does not work or if adverse reactions occur.

Psoriasis Prevention: There is no way to really prevent Psoriasis, but the follo

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ing things may help stop the flareups and lessen symptoms: Keep your skin moist and lubricated. Cold weather may worsen symptoms, while hot, humid weather and sunlight may improve symptoms. Avo

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

id scratching and digging the skin. An injury to the skin can cause psoriasis patches to form anywhere on the body, including the site of the injury. This includes injuries to your nails or nea

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

rby skin while trimming your nails. Avoid stress and anxiety. Stress may cause psoriasis to appear suddenly (flare) or can make symptoms worse, although this has not been proven in studies. Avo

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

id infection. Infections such as strep throat can cause psoriasis to appear suddenly, especially in children.

There is a website that provides cures, facts and other great information on Psori

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ou may publish this article in your ezine, newsletter, or on your web site as long as it is reprinted in its entirety and without modification except for formatting needs or grammar corrections

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/241852/advicepool-Psoriasis--The-Simple-Facts-And-The-Cures.html">Psoriasis - The Simple Facts And The Cures</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/241852/advicepool-Psoriasis--The-Simple-Facts-And-The-Cures.html]Psoriasis - The Simple Facts And The Cures[/url]

Men and women the world over have long sought out ways to make their hair grow faster, thicker, and healthier. With the onset of so many quick grow formulas and hair vitamins, it now seems to be possible to grow your hair quicker. But do they really work?

When you are depressed you need to make sure not become dependant on someone else.

Tags

Links

Advice Pool - Psoriasis - The Simple Facts And The Cures

Related Articles: